GGrantIndex
Sort

39,280 grants matching leukemia

Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging

$679,961
Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

High parameter fluorescence activated cell sorter

$679,925
Michael W Deininger · Versiti Blood Health, Inc. · S10 · FY2025 · OD

Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL

$679,885
Peter D. Cole · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA

Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.

$679,845
Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · R01 · FY2024 · HL

Kinetic Biomarker for CLL Prognosis

$679,502
Scott M Turner · Kinemed, Inc. · R44 · FY2007 · CA

Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge

$679,409
Brenda Marie Sandmaier · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA

Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia

$679,353
Martin Carroll · University Of Pennsylvania · R01 · FY2015 · CA

NOVEL APPROACHES TO ANTITUMOR DRUG DESIGN

$679,290
University Of Arizona · R35 · FY2000 · CA

Medical University of South Carolina NCORP Minority/Underserved Community Site

$679,181
Chanita A Hughes-Halbert · Medical University Of South Carolina · UG1 · FY2015 · CA

Genetic pleiotropy across pediatric cancers, and cancer-related outcomes

$679,091
Zhaoming Wang · St. Jude Children'S Research Hospital · R01 · FY2025 · CA

Adaptive epigenetic mechanisms of beta and immune cells in autoimmune diabetes

$679,061
Kevan C Herold · Yale University · R01 · FY2022 · DK

Targeted Small Molecule Inhibitors for Inv(16) Leukemia

$678,851
John Hackett Bushweller · University Of Virginia · R01 · FY2021 · CA

Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children

$678,833
Paul W. Burridge · Northwestern University At Chicago · R01 · FY2025 · CA

Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children

$678,833
Paul W. Burridge · Northwestern University At Chicago · R01 · FY2024 · CA

Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children

$678,833
Paul W. Burridge · Northwestern University At Chicago · R01 · FY2023 · CA

Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance

$678,713
Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2018 · CA

Neurostimulation in Adult Survivors of Childhood Leukemia

$678,616
Tara M Brinkman · St. Jude Children'S Research Hospital · R01 · FY2019 · CA

Predicting and Monitoring for Cardiac Toxicity in Pediatric AML

$678,486
Richard Aplenc · Children'S Hosp Of Philadelphia · R01 · FY2025 · HL

Interrogating the minor spliceosome to understand and treat leukemia

$678,479
Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

TARGETING PCD FOR CANCER THERAPY

$678,476
University Of Michigan At Ann Arbor · P01 · FY2000 · CA

CORE II - Genetics & Informatics Using Statistics CORE (GENIUS)

$678,342
Nancy J. Cox · University Of Chicago · U01 · FY2012 · GM

Neurostimulation in Adult Survivors of Childhood Leukemia

$678,341
Tara M Brinkman · St. Jude Children'S Research Hospital · R01 · FY2020 · CA

Genetic Predisposition to Chronic Lymphocytic Leukemia (CLL)

$678,292
Jennifer R Brown · Dana-Farber Cancer Inst · R01 · FY2021 · CA

A decisional intervention for older adults with acute myeloid leukemia and their caregivers

$678,204
Kah Poh Loh · University Of Rochester · R01 · FY2025 · CA

Selective treatment of acute myeloid leukemia with radioimmunotherapies targeting the active conformation of integrin beta-2

$678,101
Arun P. Wiita · University Of California, San Francisco · R01 · FY2025 · CA